top of page

Obefazimod in Focus:

Revolutionizing IBD Through a New Mechanism of Action

Thursday, February 19, 2026 • 14:00–14:20 CEST • Meeting Room A10

Thursday, February 19, 2026
14:00–14:20 CEST
Meeting Room A10

Obefazimod is an investigational agent not approved by any health regulatory agencies.

Please click the buttons below to access the symposium materials

Presentation Slide Deck
Symposium Recording
Assets-01.png
bottom of page